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endoscopic polypectomy in patients with at least one polyp 
≥6 mm in diameter detected at CTC is recommended, con-
sidering surveillance only in case polyp removal is not pos-
sible. Knowledge about CTC is in continuous evolution and 
this means that a revision might be necessary in the future 
as new data appear.
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The twentieth anniversary of CT colonography (CTC) 
(1994–2014) sets another milestone in the history of this 
technique, following the publications of the first two ran-
domized clinical trials on asymptomatic subjects [1] and 
symptomatic patients [2, 3], respectively, and the updated 
edition of guidelines on CTC examination protocols [4]. In 
fact, the first guideline on indications for CTC was recently 
and simultaneously published on European Radiology 
[5], the official journal of the European Society of Radiol-
ogy (ESR) and its sub-specialty societies, in this case the 
European Society of Gastrointestinal and Abdominal Radi-
ology (ESGAR), and on Endoscopy [6], the official jour-
nal of the European Society of Gastrointestinal Endoscopy 
(ESGE). This guideline, the result of the collaboration 
between ESGAR and ESGE was generated jointly by a team 
of researchers, including gastrointestinal radiologists and 
endoscopists, and represents the first full collaborative effort 
between the two specialties after years of turf battles involv-
ing CTC and Colonoscopy (CS). Simultaneous publication 
in the respective leading European journals, and particularly, 
in the endoscopic journal, is an extremely important signal 
towards the full implementation of CTC in the gastroentero-
logical community, also in centres, which are still reluctant.
Abstract European Society of Gastrointestinal Endos-
copy (ESGE)–European Society of Gastrointestinal and 
Abdominal Radiology (ESGAR) guideline was generated 
jointly by a team of researchers, including gastrointestinal 
radiologists and endoscopists, and represents the first full 
collaborative effort between the two specialties after years 
of turf battles involving CT colonography (CTC) and colo-
noscopy (CS). This guideline has a main educational pur-
pose and it represents the attempt to find a consensus about 
the use of CTC in clinical practice based on the best cur-
rent available evidence. Thus, it should not be considered 
as rules for establishing a legal standard of care. Main rec-
ommendations include the use of CTC as the radiological 
examination of choice for the diagnosis of colorectal neo-
plasia, the use of CTC in the case of incomplete CS, and 
the possible use of CTC as an acceptable and equally sen-
sitive alternative for patients with symptoms suggestive of 
colorectal cancer (CRC), when CS is contraindicated or not 
possible. ESGE–ESGAR guideline does not recommend 
CTC for population screening, but considers that CTC 
may be proposed as a CRC screening test on an individ-
ual basis (opportunistic screening) provided the screenee 
is adequately informed about test characteristics, benefits 
and risks. With regard to patient management, referral for 
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ESGE–ESGAR guideline gives an updated and shared 
view about CTC in different situations encountered during 
clinical practice and related to colorectal cancer diagnosis.
The first statement, on one side, recommends CTC as the 
radiological examination of choice for the diagnosis of colo-
rectal neoplasia, and on the other side, does not recommend 
barium enema (BE) in this setting any more. Although obvi-
ous in academic and non-academic referral centres, the use 
of CTC is still far to be implemented in local environments 
where turf battles still exist, because radiologists are often 
not trained and therefore may not have adequate expertise to 
implement CTC in the local practice.
Reasons for discouraging the use of BE are plenty, 
but probably unknown to the medical community outside 
research centres. With the term medical, we refer not at 
radiologists and GI specialists, but particularly to general 
practitioners, who are in many cases unaware of the advan-
tages of CTC in comparison with BE and the absolutely 
clear disadvantages of BE, namely lower sensitivity and 
specificity than CTC for detecting colorectal polyps > or 
=6 mm, which are the lesions recommend for polypectomy 
[7], higher patient discomfort [8] and higher level of radia-
tion exposure [9].
The most important indication for CTC remains incom-
plete CS, to be performed preferably on the same day. This 
is technically feasible, even with the use of faecal tagging 
[10], unless reason for stopping CS was poor bowel prepa-
ration. In that case, the exam needs to be rescheduled on a 
different day with a new bowel preparation. Delay of CTC 
for approximately 2 weeks should also be considered after 
an endoscopic resection [5, 6]. If the reason for incomplete 
CS was an obstructing colorectal cancer, good clinical 
practice includes the use of intravenous contrast medium 
to perform a complete pre-operative staging of the neoplas-
tic lesion [11]. Although incomplete CS might seem, to a 
non-expert observer, a minor indication for CTC, it is not. 
In fact, rate of incomplete CS is relatively high and it is in 
relation with the skill of the colonoscopist and the age of 
the population. In a recent Italian survey, caecal intubation 
rate was 80.7 % [12]. Moreover, more and more frequently, 
elderly and frail patients, with significant comorbidities 
and/or in therapy with anticoagulant drugs, are immedi-
ately referred to CTC after a first unsuccessful attempt with 
CS. This is reasonable since in this sub-group of patients 
risks of either perforation [13] or bleeding [14] during 
CS are extremely high and diagnostic accuracy of CTC is 
absolutely adequate to either confirm or rule out CRC.
Thanks to the recent publication of the data of SIGGAR 
trial [2, 3], a randomized clinical trial comparing CTC 
diagnostic accuracy for CRC or significant (≥1 cm) polyps 
with either CS or BE in two different arms, ESGE/ESGAR 
recommends CTC as an acceptable and equally sensitive 
alternative for patients with symptoms suggestive of CRC, 
when CS is contraindicated or not possible. This opens the 
doors of CTC to symptomatic patients, considering the 
extremely low positive predictive value of alarm symp-
toms [15]. Nonetheless, the ability to detect and remove 
early colonic lesions, the possibility to perform histologic 
analysis of diagnosed CRC and the higher sensitivity for 
the detection of colitis and anal pathology remain poten-
tial advantages of CS over CTC. On the other side, diver-
ticulosis, one of the major causes of nonspecific abdomi-
nal symptoms in the elderly is better diagnosed with CTC 
[2]. Further research is needed in this area to better stratify 
the patients to refer those with higher probability to find a 
lesion to CS and the others to CTC.
Another important problem encountered in clinical prac-
tice is the need for endoscopic polypectomy after a lesion 
is detected at CTC. ESGE–ESGAR recommends the refer-
ral to polypectomy in case of polyps ≥6 mm in diameter 
detected at CTC, and suggests CTC surveillance only in 
those who do not undergo polypectomy for any reason. 
This statement is based on consistent and robust data about 
the high rate of advanced adenomas (AAs) among large 
(≥10 mm) polyps [16] and the still unknown prevalence of 
AAs among small (6–9 mm) lesions [17].
The position of the two societies about the use of CTC 
for CRC screening is clear and it is in line with European 
Union (EU) recommendations, suggesting faecal occult 
blood test as the method of choice for CRC screening in 
Europe [18]. For this reason, ESGE and ESGAR do not 
recommend CTC as a primary test for population screen-
ing, but since there is clear evidence of the high diagnos-
tic accuracy of CTC, both societies consider that CTC 
may be proposed as a CRC screening test on an individual 
basis provided the screenee is adequately informed about 
test characteristics, benefits, and risks. This statement fol-
lows the recommendation of the American Cancer Society 
in 2008 that included CTC in the list of optional screening 
tests for asymptomatic average-risk individuals [19].
Concerning screening for individuals with a positive first-
degree family history of CRC, the evidence is still limited 
[20] and at the moment clear recommendations cannot be 
provided. This is similar to the potential use of CTC for sur-
veillance after curative-intent resection of CRC or in patients 
with high-risk polyps in surveillance after polypectomy. In 
both situations, CS is still the examination of choice and 
CTC should be considered only if CS is unfeasible.
Finally, CTC is contraindicated in patients with active 
colonic inflammation and in those who have recently 
undergone colorectal surgery.
Other statements of great interest for those performing 
or willing to perform CTC are available in the full papers, 
downloadable from the web.
ESGE–ESGAR guideline represents the first attempt of 
a radiological and a gastroenterological endoscopic society 
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to find a consensus about the use of CTC in clinical prac-
tice based on the best current available evidence. This 
guideline has a main educational purpose and it should not 
be considered as rules for establishing a legal standard of 
care. Knowledge about CTC is in continuous evolution and 
this means that a revision might be necessary in the future 
as new data appear. In any case, we wish that this publica-
tion will help overcome turf battles between CTC and CS, 
still present in local practice.
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